Individualized antiplatelet therapy after drug-eluting stent deployment: Implication of clinical trials of different durations of dual antiplatelet therapy

MLA

Raisuke Iijima, et al. “Individualized Antiplatelet Therapy after Drug-Eluting Stent Deployment: Implication of Clinical Trials of Different Durations of Dual Antiplatelet Therapy.” Journal of Cardiology, vol. 70, Dec. 2017, pp. 511–17. EBSCOhost, https://doi.org/10.1016/j.jjcc.2017.06.003.

APA

Raisuke Iijima, Masahide Tokue, Nobutaka Ikeda, Ryo Fukui, Masato Nakamura, Norihiro Kougame, Fumiyuki Hayashi, Mami Watanabe, Hidehiko Hara, Hiroki Takenaka, & Tsuyoshi Ono. (2017). Individualized antiplatelet therapy after drug-eluting stent deployment: Implication of clinical trials of different durations of dual antiplatelet therapy. Journal of Cardiology, 70, 511–517. https://doi.org/10.1016/j.jjcc.2017.06.003

Chicago

Raisuke Iijima, Masahide Tokue, Nobutaka Ikeda, Ryo Fukui, Masato Nakamura, Norihiro Kougame, Fumiyuki Hayashi, et al. 2017. “Individualized Antiplatelet Therapy after Drug-Eluting Stent Deployment: Implication of Clinical Trials of Different Durations of Dual Antiplatelet Therapy.” Journal of Cardiology 70 (December): 511–17. doi:10.1016/j.jjcc.2017.06.003.